revisiones sistematicas y metaanalisis
DESCRIPTION
Systematic reviews & Metaanalysis What is a systematic review? • It is a structured review integrating statistical analysis of the results from a collection of individual studies. A statistical analysis that combines or the results of several independent clinical trials '.'combinable integratesTRANSCRIPT
![Page 1: Revisiones sistematicas y Metaanalisis](https://reader035.vdocuments.net/reader035/viewer/2022081511/568bd58d1a28ab203498e225/html5/thumbnails/1.jpg)
Systematic reviews&
Meta-analysis
![Page 2: Revisiones sistematicas y Metaanalisis](https://reader035.vdocuments.net/reader035/viewer/2022081511/568bd58d1a28ab203498e225/html5/thumbnails/2.jpg)
What is a systematic review?
• It is a structured review integrating statistical analysis of the results from a collection of individual studies.
![Page 3: Revisiones sistematicas y Metaanalisis](https://reader035.vdocuments.net/reader035/viewer/2022081511/568bd58d1a28ab203498e225/html5/thumbnails/3.jpg)
Meta-analysis
A statistical analysis that combines or integrates
the results of several independent clinical trials
considered by the reviewer to be 'combinable'.
![Page 4: Revisiones sistematicas y Metaanalisis](https://reader035.vdocuments.net/reader035/viewer/2022081511/568bd58d1a28ab203498e225/html5/thumbnails/4.jpg)
Significance of Meta-analysis Example
Mitchell JRA. Timolol after myocardial infarction: an answer or a new set of questions? BMJ 1981;282:1565-70:
"despite claims that they reduce arrhythmias, cardiac work, and infarct size, we still have no clear evidence that ß blockers improve long-term survival after infarction
despite almost 20 years of clinical trials".
![Page 5: Revisiones sistematicas y Metaanalisis](https://reader035.vdocuments.net/reader035/viewer/2022081511/568bd58d1a28ab203498e225/html5/thumbnails/5.jpg)
Graphic Display:ß blockers in
secondary prevention after
myocardial infarction.
![Page 6: Revisiones sistematicas y Metaanalisis](https://reader035.vdocuments.net/reader035/viewer/2022081511/568bd58d1a28ab203498e225/html5/thumbnails/6.jpg)
Cumulative Meta-analysis
![Page 7: Revisiones sistematicas y Metaanalisis](https://reader035.vdocuments.net/reader035/viewer/2022081511/568bd58d1a28ab203498e225/html5/thumbnails/7.jpg)
Steps to do
• Well-Formulated Question• Efficient Search Strategies• Review Abstracts to Determine Eligibility• Apply Strict Inclusion/Exclusion Criteria• Extract the Data• Perform the Required Analyses (Meta-analysis)• Interpret the Results• Determine Implications for Health Care Policy and
Practice
![Page 8: Revisiones sistematicas y Metaanalisis](https://reader035.vdocuments.net/reader035/viewer/2022081511/568bd58d1a28ab203498e225/html5/thumbnails/8.jpg)
Methodology• At least 3 reviewers• Trial design characteristics:
Method of randomisation Design (e.g. parallel or crossover) blinding power calculation Source of any funding Allocation concealment : adequate (A), unclear (B), or inadequate (C).
![Page 9: Revisiones sistematicas y Metaanalisis](https://reader035.vdocuments.net/reader035/viewer/2022081511/568bd58d1a28ab203498e225/html5/thumbnails/9.jpg)
Description of studies
• Why included / excluded• Quality of included studies in details• Sample size of each
![Page 10: Revisiones sistematicas y Metaanalisis](https://reader035.vdocuments.net/reader035/viewer/2022081511/568bd58d1a28ab203498e225/html5/thumbnails/10.jpg)
Standardization of measures of outcome
Odds and odds ratio
The odds is the number of patients who fulfill the criteria for a given endpoint divided by the number of patients who do not.
For example, the odds of diarrhoea during treatment with an antibiotic in a group of 10 patients may be 4 to 6 (4 with diarrhoea divided by 6 without, 0.66); in a control group the odds may be 1 to 9 (0.11). The odds ratio of treatment to control group would be 6 (0.66÷0.11).
![Page 11: Revisiones sistematicas y Metaanalisis](https://reader035.vdocuments.net/reader035/viewer/2022081511/568bd58d1a28ab203498e225/html5/thumbnails/11.jpg)
Risk and relative risk
The risk is the number of patients who fulfil the criteria for a given end point divided by the total number of patients .
For example, the risk of diarrhoea during treatment with an antibiotic in a group of 10 patients may be 4 to 10; in the control group the risks may be 1 to 10. The relative risk of treatment to control group would be 4 (0.4÷0.1)
![Page 12: Revisiones sistematicas y Metaanalisis](https://reader035.vdocuments.net/reader035/viewer/2022081511/568bd58d1a28ab203498e225/html5/thumbnails/12.jpg)
Some Controversies About Meta-Analysis
• Quality of Studies• Many Small Studies or One Big Study?• Publication Bias• Fixed- or Random-Effects Models?
![Page 13: Revisiones sistematicas y Metaanalisis](https://reader035.vdocuments.net/reader035/viewer/2022081511/568bd58d1a28ab203498e225/html5/thumbnails/13.jpg)
Repeat the analysis
• Excluding the unpublished studies (if there were any)
• Excluding studies of the lowest quality• If there were one or more very large studies,
the analysis would be repeated excluding them to look at how much they dominate the results.
![Page 14: Revisiones sistematicas y Metaanalisis](https://reader035.vdocuments.net/reader035/viewer/2022081511/568bd58d1a28ab203498e225/html5/thumbnails/14.jpg)
Publication Bias
![Page 15: Revisiones sistematicas y Metaanalisis](https://reader035.vdocuments.net/reader035/viewer/2022081511/568bd58d1a28ab203498e225/html5/thumbnails/15.jpg)
Select your statistical model
• Fixed effects: Assumes that there is a single fixed treatment effect = no interaction between study and effect of intervention
• Random effects: Assumes different treatment effects of the intervention in different studies
![Page 16: Revisiones sistematicas y Metaanalisis](https://reader035.vdocuments.net/reader035/viewer/2022081511/568bd58d1a28ab203498e225/html5/thumbnails/16.jpg)
Random-Effects Models
• the confidence interval will be wider =• less certainty in conclusions
• The Cochrane Library use Fixed effect model
![Page 17: Revisiones sistematicas y Metaanalisis](https://reader035.vdocuments.net/reader035/viewer/2022081511/568bd58d1a28ab203498e225/html5/thumbnails/17.jpg)
Human Albumin Model
• The objective was to review the effectiveness of human albumin administration in prevention of severe ovarian hyperstimulation syndrome
![Page 18: Revisiones sistematicas y Metaanalisis](https://reader035.vdocuments.net/reader035/viewer/2022081511/568bd58d1a28ab203498e225/html5/thumbnails/18.jpg)
Search strategy
• MEDLINE, • EMBASE, • The MDSG specialised register• Abstracts from conferences• handsearching of core journals • contact with authors of relevant papers.
![Page 19: Revisiones sistematicas y Metaanalisis](https://reader035.vdocuments.net/reader035/viewer/2022081511/568bd58d1a28ab203498e225/html5/thumbnails/19.jpg)
• Selection criteria
• Only randomised controlled studies
![Page 20: Revisiones sistematicas y Metaanalisis](https://reader035.vdocuments.net/reader035/viewer/2022081511/568bd58d1a28ab203498e225/html5/thumbnails/20.jpg)
R.R
![Page 21: Revisiones sistematicas y Metaanalisis](https://reader035.vdocuments.net/reader035/viewer/2022081511/568bd58d1a28ab203498e225/html5/thumbnails/21.jpg)
NNT
• 2.2% in albumin group / 7.7% in control group
• absolute risk reduction was 5.5%• NNT = 1/ARR• For every 18 women at risk of severe
OHSS, albumin infusion will save one more case.
![Page 22: Revisiones sistematicas y Metaanalisis](https://reader035.vdocuments.net/reader035/viewer/2022081511/568bd58d1a28ab203498e225/html5/thumbnails/22.jpg)
Caution
• Whether this NNT would justify the routine use of albumin infusion in cases at risk of severe OHSS needs to be judged by clinical decision makers.
![Page 23: Revisiones sistematicas y Metaanalisis](https://reader035.vdocuments.net/reader035/viewer/2022081511/568bd58d1a28ab203498e225/html5/thumbnails/23.jpg)
Keep in mindEvidence may change with more trials
![Page 24: Revisiones sistematicas y Metaanalisis](https://reader035.vdocuments.net/reader035/viewer/2022081511/568bd58d1a28ab203498e225/html5/thumbnails/24.jpg)
Thank You